GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Inventories, Raw Materials & Components

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Inventories, Raw Materials & Components : ¥0 Mil (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Inventories, Raw Materials & Components?

Tianjin Pharmaceutical Da Ren Tang Group's inventories, raw materials & components for the quarter that ended in Mar. 2024 was ¥0 Mil.

Tianjin Pharmaceutical Da Ren Tang Group's quarterly raw materials increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥784 Mil) but then declined from Dec. 2023 (¥784 Mil) to Mar. 2024 (¥0 Mil).

Tianjin Pharmaceutical Da Ren Tang Group's annual raw materials declined from Dec. 2021 (¥599 Mil) to Dec. 2022 (¥483 Mil) but then increased from Dec. 2022 (¥483 Mil) to Dec. 2023 (¥784 Mil).


Tianjin Pharmaceutical Da Ren Tang Group Inventories, Raw Materials & Components Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Inventories, Raw Materials & Components Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 478.49 533.01 599.48 482.87 783.53

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 715.54 - 783.53 -

Tianjin Pharmaceutical Da Ren Tang Group Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Traded in Other Exchanges
Address
No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines